Maxim Group Downgrades Abeona Therapeutics (ABEO) to Hold Aug 15, 2019 07:47AM
Abeona Announces Closing of $92 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Oct 19, 2017 09:39AM
Abeona Therapeutics (ABEO) Prices 5M Share Common Offering at $16/Sh Oct 17, 2017 05:44AM
Abeona Therapeutics Announces Pricing of Public Offering of Common Stock Oct 16, 2017 09:45PM
Abeona Therapeutics (ABEO) PT More than Doubled to $35 at Maxim Group Oct 5, 2017 06:53AM


Jul 18, 2017 01:42PM Abeona Therapeutics (ABEO) PT Raised to $17 at Maxim Group
Apr 10, 2017 02:13PM Maxim Group Reiterates Buy Rating and $14 PT on Abeona Therapeutics (ABEO) Ahead of ABO-102 Incremental Data Presentation on 4/11
Mar 3, 2017 07:44AM Abeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in Shanghai
Feb 17, 2017 02:29PM Maxim Group Reiterates Buy on Abeona Therapeutics (ABEO) Following ABO-102 Update
Dec 12, 2016 03:52PM Maxim Group Maintains Bullish View on Abeona Therapeutics (ABEO) Amid Short Report
Nov 1, 2016 10:23AM Abeona Therapeutics Inc. Announces Closing of its Underwritten Offering of Common Stock
Oct 27, 2016 09:13AM Abeona Therapeutics (ABEO) Prices 6M Shares at $7/Share
Oct 27, 2016 09:12AM Abeona Therapeutics Announces Pricing of Public Offering of Common Stock
Oct 5, 2016 10:42AM Maxim Group Maintains Bullish View on Abeona Therapeutics (ABEO) After Safety Hurdle Cleared
Sep 29, 2016 07:58AM Abeona Therapeutics (ABEO): Visibility Improves Multiple, Raising PT - Maxim
Sep 21, 2016 03:55PM Abeona Therapeutics (ABEO) PT Raised to $8 at Maxim Group
Dec 15, 2015 04:48PM Maxim Group Starts Abeona Therapeutics (ABEO) at Buy